Boston, MA, United States of America

Lee Adam Wheeler

This inventor holds 3 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Children's Medical Center Corporation. Active years: 2019-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lee Adam Wheeler. Retrieved from https://idiyas.com/inventor/lee-adam-wheeler

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


 

Average Co-Inventor Count = 2.6

ph-index = 1


Company Filing History:


Years Active: 2019-2021

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Lee Adam Wheeler: Innovator in Cancer Treatment

Introduction

Lee Adam Wheeler is a notable inventor based in Boston, MA (US). He has made significant contributions to the field of cancer treatment, holding a total of 3 patents. His work focuses on innovative methods and compositions that aim to improve therapeutic outcomes for cancer patients.

Latest Patents

Wheeler's latest patents include groundbreaking methods and compositions for the treatment of cancer. These patents describe innovative approaches, such as the use of aptamer-siRNA chimera molecules specifically targeting breast cancer. His research is pivotal in advancing treatment options for this challenging disease.

Career Highlights

Wheeler is currently associated with the Children's Medical Center Corporation, where he continues to develop and refine his innovative ideas. His work is characterized by a commitment to improving patient care through scientific advancements.

Collaborations

Wheeler collaborates with esteemed colleagues, including Judy Lieberman and Adi Gilboa-Geffen. These partnerships enhance the research and development of effective cancer treatments.

Conclusion

Lee Adam Wheeler's contributions to cancer treatment through his patents and collaborations highlight his dedication to innovation in the medical field. His work continues to inspire advancements that may significantly impact patient care in oncology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…